www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHTue, 30 Jun 2026 16:17:21 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netTue, 30 Jun 2026 14:20:01 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-issues-chairman-s-update-highlighting-sales-growth-and-strategic-progress-15772826

EQS-News: BioElectronics Corporation / Key word(s): Financial BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress 30.06.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-issues-chairman-s-update-highlighting-sales-growth-and-strategic-progress-15772826Wed, 17 Jun 2026 16:20:21 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-advances-actipatch-commercial-rollout-with-electrome-15750296 EQS-News: BioElectronics Corporation / Key word(s): Healthcare BioElectronics Advances ActiPatch Commercial Rollout With Electrome 17.06.2026 / 16:20 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-advances-actipatch-commercial-rollout-with-electrome-15750296Wed, 22 Apr 2026 14:23:31 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-actipatch-expands-to-taiwan-challenging-traditional-pain-management-with-drug-free-innovation-15626805 EQS-News: BioElectronics Corporation / Key word(s): Financial ActiPatch Expands to Taiwan, Challenging Traditional Pain Management With Drug-Free Innovation 22.04.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-actipatch-expands-to-taiwan-challenging-traditional-pain-management-with-drug-free-innovation-15626805Wed, 11 Mar 2026 13:35:01 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-announces-issuance-of-u-s-patent-supporting-its-biodegradable-naltrexone-implant-technology-15549060 EQS-News: BioCorRx Inc / Key word(s): Healthcare BioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-announces-issuance-of-u-s-patent-supporting-its-biodegradable-naltrexone-implant-technology-15549060Wed, 14 Jan 2026 14:32:51 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-announces-initiation-of-clinical-study-by-majority-owned-subsidiary-biocorrx-pharmaceuticals-inc-evaluating-long-acting-naltrexone-implant-with-or-without-bupropion-15414739 EQS-News: BioCorRx Inc / Key word(s): Financial BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-announces-initiation-of-clinical-study-by-majority-owned-subsidiary-biocorrx-pharmaceuticals-inc-evaluating-long-acting-naltrexone-implant-with-or-without-bupropion-15414739Tue, 06 Jan 2026 14:32:52 +0100https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-announces-appointment-of-louis-lucido-as-board-chair-15395311 EQS-News: BioCorRx Inc / Key word(s): Financial BioCorRx Announces Appointment of Louis Lucido as Board Chair 06.01.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-announces-appointment-of-louis-lucido-as-board-chair-15395311